How Long Do Myasthenia Gravis Medications Take to Work?
At a Glance
Symptom relief medications like Pyridostigmine (Mestinon) work quickly, usually within 15 to 30 minutes. However, long-term immunosuppressants that treat the root cause of myasthenia gravis, such as Prednisone or Azathioprine, can take weeks to several months to reach their full effect.
In this answer
3 sections
When you begin taking medication for myasthenia gravis (MG), it is completely natural to want immediate relief from muscle weakness and fatigue. However, managing treatment expectations is critical, as different medications work on very different timelines. Rapid symptom relief from medications like Pyridostigmine (Mestinon) takes about 15 to 30 minutes, whereas long-term immunosuppressants (like Prednisone, Azathioprine, or Mycophenolate) can take weeks to several months to reach their peak effect.
Fast-Acting Symptom Relief
Pyridostigmine (often known by the brand name Mestinon) is usually the first medication prescribed for MG. It is a symptomatic treatment, meaning it improves communication between your nerves and muscles but does not alter the underlying autoimmune disease process.
- Onset: You can typically expect to feel the effects quickly, often within 15 to 30 minutes, providing an immediate boost to your muscle strength [1].
- Peak and Duration: The medication reaches its peak effect in your body within 1 to 2 hours [2]. Because its half-life (how long it stays active in your bloodstream) is short, the benefits are temporary, meaning most patients need to take it several times a day [2].
- Common Side Effects: Because it stimulates nerves, it can cause gastrointestinal side effects like stomach cramping or diarrhea. Taking it with food can help minimize these issues.
Medium to Long-Term Disease Modification
To treat the root cause of MG, doctors use immunosuppressants to calm your overactive immune system. These medications operate on a “marathon” timeline rather than a “sprint,” and because they suppress your immune system, they carry an increased risk of infections.
Prednisone (Corticosteroids)
Prednisone is often considered a first-line immunotherapy because it begins working faster than other immune-suppressing drugs [3].
- Onset: Many patients begin to notice clinical improvements within a few weeks [3].
- Peak Effect: It often takes several weeks to a few months to reach its peak effectiveness. For example, some evidence shows it takes a median of 14 weeks for patients to achieve a state where they have minimal symptoms [4].
- Important Safety Warning: In some cases, starting high doses of corticosteroids can trigger a temporary worsening of symptoms during the first couple of weeks [5]. If this worsening affects your ability to breathe, speak, or swallow, it is a medical emergency (a myasthenic crisis). Seek emergency medical care immediately.
Azathioprine and Mycophenolate Mofetil
Medications like Azathioprine (Imuran) and Mycophenolate Mofetil (CellCept) are widely used for long-term maintenance. They are often called steroid-sparing agents because they help you gradually reduce your reliance on prednisone while keeping your symptoms under control [6][7].
- Onset and Peak Effect: These medications have a very slow onset of action. It can take several months before you begin to notice any benefit [7][8]. Some evidence suggests Mycophenolate may provide slightly faster symptom control than Azathioprine, but achieving their full peak therapeutic effect can still take anywhere from 6 months up to 1 to 2 years [9][6]. Because of how they work, your doctor will likely require regular blood tests to monitor your liver and blood cell counts [10].
- Why the Wait? Because they take so long to work, your neurologist will likely have you continue taking faster-acting medications like prednisone or pyridostigmine to manage your symptoms while waiting for these long-term drugs to reach their peak [11]. Stopping these medications prematurely because they “don’t seem to be working” can lead to a significant risk of symptom flare-ups [9].
Setting Realistic Expectations
The journey to controlling MG often requires patience. Your doctor will likely combine different medications—using fast-acting drugs for daily functioning and slow-acting drugs to stabilize your immune system over the long term.
Tracking your daily symptoms can help your care team adjust your treatment plan to bridge any gaps in your symptom relief. Consider writing down:
- The exact time you take your medication.
- The time your symptoms start to return (the “wearing off” effect).
- Specific issues you notice, such as eyelid drooping, difficulty chewing, or arm weakness.
Common questions in this guide
How fast does Mestinon (Pyridostigmine) work?
Why do I need to keep taking Mestinon if I am on other MG medications?
Can starting Prednisone make myasthenia gravis worse?
How long does it take for Azathioprine or Mycophenolate to work?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I experience gastrointestinal side effects from Pyridostigmine, are there adjustments to the dose or timing we can make, or other medications that can help?
- 2.What specific signs should I watch for when starting Prednisone that would indicate a myasthenic crisis requiring an ER visit versus a normal, temporary worsening?
- 3.Since Azathioprine and Mycophenolate take months to work, what is our plan for managing my daily symptoms in the meantime?
- 4.How frequently will I need blood tests to monitor for side effects while on immunosuppressants?
- 5.What should I do if I accidentally miss a dose of my fast-acting medication like Pyridostigmine?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Pyridostigmine improves hand grip strength in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Schlömer E, Stein E, Kedor C, et al.
Frontiers in neuroscience 2025; (19()):1637838 doi:10.3389/fnins.2025.1637838.
PMID: 40970182 - 2
Clinical pharmacokinetics of cholinesterase inhibitors.
Aquilonius SM, Hartvig P
Clinical pharmacokinetics 1986; (11(3)):236-49 doi:10.2165/00003088-198611030-00005.
PMID: 3524957 - 3
What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?
Vanoli F, Mantegazza R
Expert opinion on pharmacotherapy 2022; (23(13)):1471-1474 doi:10.1080/14656566.2022.2122710.
PMID: 36104973 - 4
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.
Narayanaswami P, Sanders DB, Wolfe G, et al.
Neurology 2021; (96(3)):114-122 doi:10.1212/WNL.0000000000011124.
PMID: 33144515 - 5
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.
Lotan I, Hellmann MA, Wilf-Yarkoni A, Steiner I
Journal of neurology 2021; (268(12)):4573-4586 doi:10.1007/s00415-020-10264-0.
PMID: 33064188 - 6
Effectiveness and Safety of Mycophenolate Mophetil in Myasthenia Gravis: A Real-Life Multicenter Experience.
Vinciguerra C, D'Amico A, Bevilacqua L, et al.
Brain sciences 2024; (14(8)) doi:10.3390/brainsci14080774.
PMID: 39199468 - 7
Methotrexate in generalized myasthenia gravis: a systematic review.
Prado MB, Adiao KJB
Acta neurologica Belgica 2023; (123(5)):1679-1691 doi:10.1007/s13760-023-02242-w.
PMID: 36967437 - 8
Novel Treatments in Myasthenia Gravis.
Menon D, Barnett C, Bril V
Frontiers in neurology 2020; (11()):538 doi:10.3389/fneur.2020.00538.
PMID: 32714266 - 9
Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study.
Oskarsson B, Rocke DM, Dengel K, Richman DP
Neurology 2016; (86(12)):1159-63 doi:10.1212/WNL.0000000000002405.
PMID: 26850977 - 10
A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis.
Jack KL, Koopman WJ, Hulley D, Nicolle MW
Journal of clinical neuromuscular disease 2016; (18(1)):12-20 doi:10.1097/CND.0000000000000133.
PMID: 27552384 - 11
Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial.
Sharshar T, Porcher R, Demeret S, et al.
JAMA neurology 2021; (78(4)):426-433 doi:10.1001/jamaneurol.2020.5407.
PMID: 33555314
This page is for informational purposes only and does not replace professional medical advice. Always consult your neurologist regarding your specific myasthenia gravis treatment timeline and medication side effects.
Get notified when new evidence is published on Myasthenia gravis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.